| Literature DB >> 23208371 |
Hazem S Elshafie1, Ippolito Camele, Rocco Racioppi, Laura Scrano, Nicola S Iacobellis, Sabino A Bufo.
Abstract
The trend to search novel microbial natural biocides has recently been increasing in order to avoid the environmental pollution from use of synthetic pesticides. Among these novel natural biocides are the bioactive secondary metabolites of Burkholderia gladioli pv. agaricicola (Bga). The aim of this study is to determine antifungal activity of Bga strains against some phytopathogenic fungi. The fungicidal tests were carried out using cultures and cell-free culture filtrates against Botrytis cinerea, Aspergillus flavus, Aspergillus niger, Penicillium digitatum, Penicillium expansum, Sclerotinia sclerotiorum and Phytophthora cactorum. Results demonstrated that all tested strains exert antifungal activity against all studied fungi by producing diffusible metabolites which are correlated with their ability to produce extracellular hydrolytic enzymes. All strains significantly reduced the growth of studied fungi and the bacterial cells were more bioactive than bacterial filtrates. All tested Bulkholderia strains produced volatile organic compounds (VOCs), which inhibited the fungal growth and reduced the growth rate of Fusarium oxysporum and Rhizoctonia solani. GC/MS analysis of VOCs emitted by strain Bga 11096 indicated the presence of a compound that was identified as 1-methyl-4-(1-methylethenyl)-cyclohexene, a liquid hydrocarbon classified as cyclic terpene. This compound could be responsible for the antifungal activity, which is also in agreement with the work of other authors.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23208371 PMCID: PMC3546691 DOI: 10.3390/ijms131216291
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
In vitro antagonistic activity of bacterial cultures and cell-free culture filtrates recorded as the mean diameter of fungal mycelium growth (mm) ± Standard Deviation. Values followed by the same letter in each vertical column are not significantly different according to Duncan test at p < 0.05. Data were obtained on three replicates.
| Fungal pathogens (Mean diameter of fungal mycelium growth mm ± SD) | |||||||
|---|---|---|---|---|---|---|---|
|
| |||||||
| Bacterial Filtrates | |||||||
| 11096 | 10.5 ± 2.12 c | 13.0 ± 1.41 c | 11.0 ± 1.41 c | 11.5 ± 2.12 b | 11.0 ± 1.41 b | 6.5 ± 0.71 c | 7.5 ± 0.71 b |
| 11097 | 15.5 ± 2.12 b | 18.0 ± 1.41 b | 15.0 ± 1.41 b,c | 13.0 ± 1.41 b | 13.5 ± 0.71 b | 9.5 ± 0.71 b | 10.0 ± 2.83 b |
| 12220 | 11.0 ± 1.41 b,c | 16.5 ± 0.71 b,c | 16.0 ± 1.41 b | 9.5 ± 0.71 b | 14.5 ± 0.71 b | 8.5 ± 0.71 b,c | 11.0 ± 1.41 b |
| 12322 | 14.0 ± 1.41 b,c | 16.5 ± 2.12 b,c | 15.0 ± 1.41 b,c | 7.5 ± 0.71 b | 13.5 ± 2.12 b | 9.5 ± 0.71 b | 8.5 ± 0.71 b |
| Control | 46.0 ± 1.41 a | 36.5 ± 2.12 a | 47.0 ± 2.83 a | 36.0 ± 4.24 a | 27.0 ± 2.83 a | 44.0 ± 1.41 a | 40.0 ± 1.41 a |
| 11096 | 5.5 ± 1.4 c | 12.6 ± 0.7 c | 9.0 ± 2.1 c | 6.0 ± 1.4 c | 5.0 ± 2.1 c | 6.0 ± 1.4 c | 2.5 ± 0.7 c |
| 11097 | 8.5 ± 2.1 b | 17.0 ± 0.7 b | 14.0 ± 2.1 b | 8.5 ± 2.8 b | 8.0 ± 2.8 b | 11.5 ± 2.5 b | 5.5 ± 0.7 |
| 12220 | 9.0 ± 1.4 b | 14.0 ± 1.4 b,c | 13.0 ± 2.1 b | 4.5 ± 0.7 b,c | 6.0 ± 2.1 b,c | 9.5 ± 2.1 b | 3.5 ± 0.7 b,c |
| 12322 | 8.0 ± 2.1 b | 19.0 ± 1.4 b | 14.0 ± 1.4 b | 11.5 ± 2.1 b | 9.5 ± 2.1 b | 9.5 ± 0.7 b | 7.5 ± 0.7 |
| Control | 27.5 ± 2.1 a | 48.0 ± 2.8 a | 42.0 ± 2.1 a | 39.0 ± 1.4 a | 47.0 ± 2.8 a | 44.5 ± 2.1 a | 31.5 ± 2.1 a |
Figure 1Percentage of growth inhibition (PGI) for cell-free culture filtrate and bacterial culture of Bga ICMP 11096. Bars with different letters indicate mean values significantly different at p < 0.05 according to Tukey B test. Data are expressed as mean of three replicates ± SD.
Figure 2Antifungal activity of volatile organic compounds of Bga strains vs. F. oxysporum (5 days growth). Bars with different letters indicate mean values significantly different at p < 0.05 according to Duncan test. Data are expressed as mean of three replicates ± SD.
Figure 3Effect of volatile secondary metabolites of Bga ICMP11096 on the growth rate of F. oxysporum. Data are expressed as a mean of three replicates ± SD.
Figure 4Antifungal activity of volatile secondary metabolites of Bga strains vs. R. solani (five days). Bars with different letters indicate mean values significantly different at p < 0.05 according to Duncan test. Data are expressed as mean of three replicates ± SD.
Figure 5Effect of volatile secondary metabolites of Bga 11096 on growth rate of R. solani. Data are expressed as mean of three replicates ± SD.
Figure 6Mass spectrum of the main volatile compound produced by Bga ICMP11096, a cyclic terpene (an isomer of limonene).